ECM
ISEE

Estabrook Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Estabrook Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-25
Closed -$71 – 386
2017
Q3 		$71 Sell
25
-300
-92% -$810 ﹤0.01% 390
2017
Q2 		$832 Hold
325
– – ﹤0.01% 378
2017
Q1 		$1.19K Hold
325
– – ﹤0.01% 380
2016
Q4 		$1.57K Hold
325
– – ﹤0.01% 405
2016
Q3 		$15K Hold
325
– – ﹤0.01% 327
2016
Q2 		$16.6K Hold
325
– – ﹤0.01% 327
2016
Q1 		$13.7K Hold
325
– – ﹤0.01% 334
2015
Q4 		$25.5K Hold
325
– – ﹤0.01% 294
2015
Q3 		$13.2K Buy
+325
New +$17.2K ﹤0.01% 341

Other funds holding ISEE

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Estabrook Capital Management's ISEE Position: Q4 2017 in Review

Estabrook Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2017, closing a stake of 25 shares — an estimated $71 sold.

Estabrook Capital Management first reported a position in ISEE in Q3 2015 and held it in 9 quarters. The position peaked at $25.5K in Q4 2015. 75 funds tracked by Wall St. Rank hold ISEE as of Q4 2017.

  • Estabrook Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Estabrook Capital Management sold 25 IVERIC bio, Inc. Common Stock shares in Q4 2017, an estimated $71.
  • Estabrook Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2015 and held it in 9 quarters.
  • Estabrook Capital Management's IVERIC bio, Inc. Common Stock position peaked at $25.5K in Q4 2015.
  • 75 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2017.

Based on Estabrook Capital Management's 13F filing for Q4 2017, filed 12 Feb 2018.